生殖医学杂志2026,Vol.35Issue(10):1271-1280,10.DOI:10.3969/j.issn.1004-3845.2026.10.009
基于JNK/FOXO1通路探讨褪黑素抗氧化应激保护卵巢储备功能的机制
Mechanism underlying melatonin-mediated protection of ovarian reserve against oxidative stress via the JNK/FOXO1 signaling pathway
摘要
Abstract
Objectives:To explore the mechanism by which melatonin alleviates oxidative stress(OS)injury in granulosa cells and protects ovarian reserve function. Methods:Human ovarian granulosa cell line KGN was cultured in vitro.The CCK-8 assay was employed to measure the changes in cell viability after the treatment with gradient concentrations of hydrogen peroxide(H2O2)for 12 h or 24 h,in order to establish the optimal concentration and duration for constructing the OS injury model.On this basis,different concentrations of melatonin were co-administered to determine the optimal protective concentration of melatonin.In subsequent experiments,KGN cells were divided into the following groups:control group,model group(H2O2 treatment),melatonin group(H2O2+melatonin),SP600125 group(pretreatment with JNK inhibitor+H2O2),AS1842856 group(pretreatment with FOXO1 inhibitor+H2O2),and melatonin+SP600125 or AS1842856 combination groups.Intracellular reactive oxygen species(ROS)levels were detected using the DCFH-DA fluorescent probe.Cell apoptosis was quantitatively analyzed by flow cytometry.Nuclear translocation of FOXO1 protein was observed via immunofluorescence staining.The expression levels of core proteins in the JNK/FOXO1 signaling pathway as well as apoptosis-related proteins were determined by Western blot analysis. Results:H2O2 showed concentration-dependent and time-dependent inhibitory effects on KGN cell viability.300 μmol/L H2O2 treatment for 12 h(yielding a cell survival rate of approximately 70%)was selected as the optimal condition for establishing the oxidative stress injury model in subsequent experiments,and 5 μmol/L melatonin was determined as the optimal protective concentration.Compared with the control group,the model group exhibited significantly increased intracellular ROS levels,cell apoptosis rate,and nuclear translocation of FOXO1 protein(P<0.001);Bcl-2 protein expression was significantly decreased(P<0.001),while the expression levels of Bax and Cleaved caspase-3 as well as the p-JNK/JNK ratio were markedly elevated(P<0.01).Compared with the model group,melatonin significantly reversed the H2O2-induced inhibition of KGN cell viability,and markedly reduced intracellular ROS level and cell apoptosis rate in the melatonin group(P<0.001).Immunofluorescence results demonstrated that melatonin significantly attenuated H2O2-induced FOXO1 nuclear translocation(P<0.001).Protein expression analysis revealed that,relative to those in the model group,the p-JNK/JNK ratio and the expression levels of Bax and Cleaved caspase-3 were significantly downregulated(P<0.05),whereas Bcl-2 expression was significantly upregulated(P<0.001)in the melatonin group.In the inhibitor intervention experiments,compared with the model group,administration of SP600125 or AS1842856 alone,or their combination with melatonin,all significantly suppressed the expression of Cleaved caspase3(P<0.001).However,no significant difference was observed in Cleaved caspase3 protein levels between the melatonin group and the melatonin+inhibitor combination groups(P>0.05). Conclusions:H2O2-induced OS can cause damage to KGN cells,promote intracellular accumulation of ROS,inhibit cell proliferation activity,induce apoptosis,and activate the JNK/FOXO1 signaling pathway.Melatonin can effectively facilitate the clearance of excess intracellular ROS,exert anti-OS effects,and inhibit excessive apoptosis of KGN cells.The protective effect of melatonin on KGN cells is closely associated with its inhibitory regulation of the JNK/FOXO1 signaling pathway.关键词
卵巢储备/颗粒细胞/氧化应激/褪黑素/JNK/FOXO1信号通路Key words
Ovarian reserve/Granulosa cells/Oxidative stress/Melatonin/JNK/FOXO1 signal pathway分类
医药卫生引用本文复制引用
陈文俊,张艺超,罗熙,马倩雯..基于JNK/FOXO1通路探讨褪黑素抗氧化应激保护卵巢储备功能的机制[J].生殖医学杂志,2026,35(10):1271-1280,10.基金项目
浙江省医药卫生科技计划项目(2023KY863) (2023KY863)
浙江省中医药科技计划项目(2023ZL366) (2023ZL366)